Multiple roles of angiopoietins in atherogenesis

Current Opinion in Lipidology

Volumn 22, Issue 5, 2011, Pages 380-385

  Ahmed, Asif ^a   Fujisawa, Takeshi ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

angiopoietin 1; angiopoietin 2; atherosclerosis; endothelial cells; nitric oxide

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; INTEGRIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE;

ANTIINFLAMMATORY ACTIVITY; ARTERIOSCLEROSIS; ATHEROGENESIS; CARDIAC ALLOGRAFT VASCULOPATHY; CELL ACTIVATION; CHEMOTAXIS; MONOCYTE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SMOOTH MUSCLE FIBER; UPREGULATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANGIOPOIETINS; ANIMALS; ATHEROSCLEROSIS; HUMANS; RECEPTOR, TIE-2;

MUS; RATTUS;

EID: 80052776607     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32834b26b3     Document Type: Review

References (61)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473:317-325.
2. Gibbons GH. Endothelial function as a determinant of vascular function and structure: a new therapeutic target. Am J Cardiol 1997; 79 (5A):3-8. (Pubitemid 27157072)
3. Celletti FL, Waugh JM, Amabile PG, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7:425-429. (Pubitemid 32298544)
4. Thurston G. Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 2003; 314:61-68. (Pubitemid 37409913)
5. Makinde T, Agrawal DK. Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease. J Cell Mol Med 2008; 12:810-828. (Pubitemid 351718065)
6. Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10:165-177.
7. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 2009; 29:2011-2022.
8. Valenzuela DM, Griffiths JA, Rojas J, et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 1999; 96:1904-1909. (Pubitemid 29117840)
9. Lee HJ, Cho CH, Hwang SJ, et al. Biological characterization of angiopoietin-3. and angiopoietin-4. FASEB J 2004; 18:1200-1208.
10. Chan B, Yuan HT, Ananth Karumanchi S, Sukhatme VP. Receptor tyrosine kinase Tie-1 overexpression in endothelial cells upregulates adhesion molecules. Biochem Biophys Res Commun 2008; 371:475-479.
11. Saharinen P, Kerkela K, Ekman N, et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 2005; 169:239-243. (Pubitemid 40656562)
12. Carlson TR, Feng Y, Maisonpierre PC, et al. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 2001; 276:26516-26525.
13. Ahmad S, Cudmore MJ, Wang K, et al. Angiopoietin-1 induces migration of monocytes in a tie-2 and integrin-independent manner. Hypertension 2010; 56:477-483.
14. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell 1996; 87:1161-1169. (Pubitemid 27010100)
15. Sundberg C, Kowanetz M, Brown LF, et al. Stable expression of angiopoietin-and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 2002; 82:387-401. (Pubitemid 34311112)
16. Oh H, Takagi H, Suzuma K, et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999; 274:15732-15739.
17. Mandriota SJ, Pyke C, Di Sanza C, et al. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 2000; 156:2077-2089. (Pubitemid 30641775)
18. Dumont DJ, Fong GH, Puri MC, et al. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 1995; 203:80-92.
19. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376:70-74.
20. Feistritzer C, Mosheimer BA, Sturn DH, et al. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol 2004; 114:1077-1084. (Pubitemid 39469147)
21. Lemieux C, Maliba R, Favier J, et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005; 105:1523-1530. (Pubitemid 40223669)
22. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8:211-226. (Pubitemid 41317592)
23. Jones N, Voskas D, Master Z, et al. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2001; 2:438-445. (Pubitemid 32509961)
24. DeBusk LM, Hallahan DE, Lin PC. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 2004; 298:167-177. (Pubitemid 38887316)
25. Kontos CD, Stauffer TP, Yang WP, et al. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 1998; 18:4131-4140. (Pubitemid 28287936)
26. Kim I, Kim HG, So JN, et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 30-kinase/Akt signal transduction pathway. Circ Res 2000; 86:24-29. (Pubitemid 30044164)
27. Kim I, Moon SO, Han CY, et al. The angiopoietin-Tie2 system in coronary artery endothelium prevents oxidized low-density lipoproteininduced apoptosis. Cardiovasc Res 2001; 49:872-881. (Pubitemid 32178391)
28. Kwak HJ, Lee SJ, Lee YH, et al. Angiopoietin-1 inhibits irradiationand mannitol-induced apoptosis in endothelial cells. Circulation 2000; 101:2317-2324. (Pubitemid 30317136)
29. Kim I, Moon SO, Park SK, et al. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and Eselectin expression. Circ Res 2001; 89:477-479. (Pubitemid 34132640)
30. Kim I, Oh JL, Ryu YS, et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J 2002; 16:126-128.
31. Thurston G,Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286:2511-2514.
32. Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-463. (Pubitemid 30208166)
33. Nykanen AI, Krebs R, Saaristo A, et al. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 2003; 107:1308-1314. (Pubitemid 36314416)
34. Nykanen AI, Pajusola K, Krebs R, et al. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and-2 expression in rat cardiac allograft vasculopathy. Circ Res 2006; 98:1373-1380. (Pubitemid 43948061)
35. Sullivan CC, Du L, Chu D, et al. Induction of pulmonary hypertension by an angiopoietin 1/Tie2/serotonin pathway. Proc Natl Acad Sci USA 2003; 100:12331-12336. (Pubitemid 37271560)
36. Zhao YD, Campbell AI, Robb M, et al. Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res 2003; 92:984-991. (Pubitemid 36588497)
37. Jeansson M, Gawlik A, Anderson G, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121:2278-2289.
38. Eriksson EE. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol 2004; 15:553-558. (Pubitemid 39336583)
39. Dallabrida SM, Ismail NS, Pravda EA, et al. Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy. FASEB J 2008; 22:3010-3023.
40. Hauer AD, Habets KL, van Wanrooij EJ, et al. Vaccination against Tie2 reduces atherosclerosis. Atherosclerosis 2009; 204:365-371.
41. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60. (Pubitemid 27450643)
42. Roviezzo F, Tsigkos S, Kotanidou A, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005; 314:738-744. (Pubitemid 41043857)
43. Sturn DH, Feistritzer C, Mosheimer BA, et al. Angiopoietin affects neutrophil migration. Microcirculation 2005; 12:393-403. (Pubitemid 41122464)
44. Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235-239. (Pubitemid 43214752)
45. Goettsch W, Gryczka C, Korff T, et al. Flow-dependent regulation of angiopoietin-2. J Cell Physiol 2008; 214:491-503. (Pubitemid 350309006)
46. Gale NW, Thurston G, Hackett SF, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 2002; 3:411-423.
47. Ahmed A, Fujisawa T, Niu XL, et al. Angiopoietin-2 confers atheroprotection in apoE-/-mice by inhibiting LDL oxidation via nitric oxide. Circ Res 2009; 104:1333-1336.
48. Daly C, Pasnikowski E, Burova E, et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 2006; 103:15491-15496. (Pubitemid 44625619)
49. Verbeuren TJ, Coene MC, Jordaens FH, et al. Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits. Circ Res 1986; 59:496-504. (Pubitemid 17000925)
50. Cooke JP, Singer AH, Tsao P, et al. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90:1168-1172.
51. Knowles JW, Reddick RL, Jennette JC, et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 2000; 105:451-458. (Pubitemid 30127245)
52. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002; 8:1211-1217. (Pubitemid 35373551)
53. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270:319-324.
54. Wang W, Hein TW, Zhang C, et al. Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase I. Microcirculation 2011; 18:36-45.
55. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005; 118 (Pt 4):771-780. (Pubitemid 40372585)
56. Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103:4150-4156. (Pubitemid 38685356)
57. Jaumdally RJ, Lip GY, Varma C, Blann AD. Impact of high dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes. Angiology 2011. [Epub ahead of print]
58. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999; 99:1726-1732. (Pubitemid 29162486)
59. Calvi C, Dentelli P, Pagano M, et al. Angiopoietin 2 induces cell cycle arrest in endothelial cells: a possible mechanism involved in advanced plaque neovascularization. Arterioscler Thromb Vasc Biol 2004; 24:511-518. (Pubitemid 38326146)
60. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284:1994-1998. (Pubitemid 29309448)
61. Beck H, Acker T, Wiessner C, et al. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol 2000; 157:1473-1483.